Product Advisory Board

Concert Pharmaceuticals benefits from frequent, in-depth interactions with its knowledgeable and experienced advisor team. The Product Advisory Board was established at Concert’s inception as a source of deep industry expertise to evaluate and contribute to development and commercialization strategies for the Company’s product pipeline.

Chuck Finn
CEO of RRD International; Former Senior Vice President, Quintiles

Eric Gordon
Partner Skyline Ventures; Former executive Bristol-Myers Squibb

Dan Grau
Chief Executive Officer and Vice Chair, Cortria Corporation; Former Chief Operating Officer, CombinatoRx

Peter Barton Hutt
Senior Counsel, Covington & Burling; Former Chief Counsel, FDA

Jim O'Shea
Former President & Chief Operating Officer, Sepracor

Tom Salzmann
Former Executive Vice President, Preclinical Development and Global Operations, Merck

Wendell Wierenga
Executive Vice President Research and Development Ambit; Former Senior Vice President, WW Head of R&D, Parke-Davis 

[ back to top ]